Pretreatment method, pretreatment solution, kit and use thereof for viral nucleic acid detection
A technology of pretreatment solution and viral nucleic acid, which is applied in microorganism-based methods, biochemical equipment and methods, and microbial determination/inspection, etc. Conducive to long-term storage and detection, improving detection efficiency and shortening detection time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Example 1 The present invention is used for the pretreatment and rapid detection of respiratory syncytial virus (RSV) oropharyngeal swab samples
[0054] In order to evaluate the virus pretreatment solution in this invention, the virus pretreatment solution of this invention (the concentration of Tris-HCl is 100mM, the concentration of EDTA-2Na is 10mM, the concentration of sodium chloride is 0.9% (w / v), The concentration of RNasin was 20U / mL, and the concentration of Proclin 950 was 0.04% (v / v)) were compared with normal saline and commercial virus pretreatment solution. The method for comparison is pretreatment with a clinically diagnosed positive respiratory syncytial virus (RSV) throat swab sample diluted (1:9, v / v). hours / 24 hours / 48 hours and 72 hours for direct amplification of samples, and by comparing the detection efficiency of real-time fluorescent quantitative PCR (real-timeqPCR) under room temperature pretreatment conditions by Ct value, to evaluate the eff...
Embodiment 2
[0059] Example 2 The present invention is used for nucleic acid pretreatment and rapid detection after purification of 2019 novel coronavirus (2019-nCoV) samples
[0060] In order to evaluate the virus pretreatment solution in this invention, the virus pretreatment solution of this invention (the concentration of Tris-HCl is 100mM, the concentration of EDTA-2Na is 10mM, the concentration of sodium chloride is 0.9% (w / v), The concentration of RNasin was 20U / mL, and the concentration of Proclin 300 was 0.01% (v / v)) were compared with normal saline and commercial virus pretreatment solution. The method for comparison is to dilute (1:9, v / v) pretreatment with the nucleic acid of the 2019 novel coronavirus (2019-nCoV) that is clinically diagnosed as positive. hours / 24 hours / 48 hours and 72 hours for direct amplification of samples, and by comparing the detection efficiency of real-time fluorescent quantitative PCR (real-timeqPCR) under room temperature pretreatment conditions by Ct...
Embodiment 3
[0063] Example 3 The present invention is used for pretreatment and rapid detection of enterovirus versatility (EV) throat swab samples
[0064] In order to evaluate the virus pretreatment solution in this invention, the virus pretreatment solution of this invention (the concentration of Tris-HCl is 100mM, the concentration of EDTA-2Na is 10mM, the concentration of sodium chloride is 0.9% (w / v), The concentration of SDS was 0.1%, and the concentration of Proclin950 was 0.04% (v / v)) were compared with normal saline and commercial virus pretreatment solution. The method for comparison is pretreatment with the common enterovirus (EV) throat swab samples clinically diagnosed as positive (1:9, v / v). The pretreatment condition is room temperature 25°C. Samples were directly amplified at 0 hours / 24 hours / 48 hours and 72 hours, and the detection efficiency of real-time qPCR (real-time qPCR) under room temperature pretreatment conditions was compared by Ct value to evaluate the effect ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com